It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo. The FDA approved Emblaveo, a combination of aztreonam and avibactam, for use in combination with ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

In general, strive to use antibiotics covering a spectrum no ... If oral therapy is possible: Nonsevere: metronidazole 500 mg three-times daily (t.i.d.) orally for 10 days; Severe: vancomycin ...

GBS antibiotic prophylaxis has been demonstrated ... 2008 Elsevier Science, Inc. Metronidazole (Flagyl) 500 mg orally twice a day for 7 days Metronidazole (Flagyl) 250 mg orally three times ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic. Tuberculosis is the most common infectious disease ...

Researchers at discovered a critical vulnerability in drug-resistant bacteria: zinc -- or a lack thereof. Researchers at McMaster University have discovered a critical vulnerability in drug ...